Related Experiment Video
Updated: Sep 10, 2025

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
Published on: May 12, 2023
Design of respirable sprayed microparticles of encapsulated bacteriophages
Alberto Baldelli1, Mingtao Liang2
1Faculty of Land and Food Systems, The University of British Columbia, Vancouver, BC, Canada.
Abstract:
Antibiotic resistance is exponentially increasing, and the number of deaths caused by bacterial infections is expected to surge. When dealing with the respiratory system, inefficient antibiotics heighten the chance of death from bacterial infection. However, the alternatives to antibiotics are limited. Bacteriophages are a valid option since they can target a specific type of bacterium. Bacteriophages are highly specific and can avoid any side effects when delivered. However, their poor stability makes their use inefficient. Encapsulation is commonly used to protect any bioactive compound for different types of delivery. In the case of respiratory delivery, particle engineering is used to generate stable dry powders to target the nasal or lung areas. This review article provides a guideline for engineering a process of nasal dry powders of encapsulated bacteriophages.
Insights
Antibiotic resistance is a growing threat. This review explores engineering dry powder nasal delivery of bacteriophages, a promising alternative to antibiotics for respiratory infections.
Area of Science:
- Biotechnology
- Pharmaceutical Sciences
- Infectious Diseases
Background:
- Rising antibiotic resistance necessitates novel therapeutic strategies.
- Bacterial respiratory infections pose a significant mortality risk, exacerbated by ineffective antibiotics.
- Bacteriophages offer targeted antimicrobial therapy but face stability challenges for delivery.
Purpose of the Study:
- To provide a guideline for developing encapsulated bacteriophage nasal dry powders.
- To address the challenge of bacteriophage instability for respiratory delivery.
- To explore particle engineering for stable dry powder formulations.
Main Methods:
- Review of encapsulation techniques for bioactive compounds.
- Analysis of particle engineering strategies for nasal and lung delivery.
- Guideline development for creating dry powder bacteriophage formulations.
Main Results:
- Encapsulation can protect bacteriophages from degradation.
- Particle engineering enables the creation of stable dry powders for inhalation.
- Nasal dry powders offer a targeted delivery route for bacteriophage therapy.
Conclusions:
- Encapsulated bacteriophages in dry powder nasal formulations represent a viable alternative to antibiotics.
- Particle engineering is crucial for achieving stable and effective bacteriophage delivery to the respiratory tract.
- This review offers a framework for the development of novel bacteriophage-based therapies against respiratory bacterial infections.
Related Concept Videos
Physical Methods for Controlling Microbial Growth: Radiation and Filtration
Lytic Cycle of Bacteriophages
DNA Bacteriophages

